First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients

被引：178

作者：

Pilowsky, LS ^{[1
]}

Bressan, RA

Stone, JM

Erlandsson, K

Mulligan, RS

Krystal, JH

Ell, PJ

机构：

[1] Kings Coll London, Inst Psychiat, London WC2R 2LS, England

[2] UCL, Inst Nucl Med, London, England

[3] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA

[4] VA Connecticut Healthcare Syst, West Haven, CT USA

来源：

MOLECULAR PSYCHIATRY | 2006年 / 11卷 / 02期

关键词：

D O I：

10.1038/sj.mp.4001751

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：118 / 119

页数：2

共 8 条

[1] Impact of schizophrenia and chronic antipsychotic treatment on [123I]CNS-1261 binding to N-methyl-D-aspartate receptors in vivo [J].

Bressan, RA ;

Erlandsson, K ;

Stone, JM ;

Mulligan, RS ;

Krystal, JH ;

Ell, PJ ;

Pilowsky, LS .

BIOLOGICAL PSYCHIATRY, 2005, 58 (01) :41-46

[2] Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia [J].

Coyle, JT ;

Tsai, G ;

Goff, D .

GLUTAMATE AND DISORDERS OF COGNITION AND MOTIVATION, 2003, 1003 :318-327

[3] Kinetic modelling of [123I]CNS 1261 -: a potential SPET tracer for the NMDA receptor [J].

Erlandsson, K ;

Bressan, RA ;

Mulligan, RS ;

Gunn, RN ;

Cunningham, VJ ;

Owens, J ;

Wyper, D ;

Ell, PJ ;

Pilowsky, LS .

NUCLEAR MEDICINE AND BIOLOGY, 2003, 30 (04) :441-454

[4]

Friston K.J., 1994, Human Brain Mapping, V2, P189, DOI DOI 10.1002/HBM.460020402

[5]

Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO

[6]

2-8

[7]

Stone J, 2005, SCHIZOPHRENIA BULL, V31, P446

[8] Usefulness of a three-dimensional stereotaxic ROI template on anatomically standardised 99mTc-ECD SPET [J].

Takeuchi, R ;

Yonekura, Y ;

Matsuda, H ;

Konishi, J .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (03) :331-341

← 1 →